Jeffrey E. Saffitz

Active 1983–2025

112
Papers
26,642
Citations
91
h-index
108
i10-index

Citations

Citations per year for Jeffrey E. Saffitz1984: 1 citations1985: 6 citations1986: 4 citations1987: 12 citations1988: 15 citations1989: 17 citations1990: 17 citations1991: 21 citations1992: 23 citations1993: 28 citations1994: 47 citations1995: 78 citations1996: 61 citations1997: 83 citations1998: 120 citations1999: 144 citations2000: 186 citations2001: 162 citations2002: 185 citations2003: 241 citations2004: 309 citations2005: 210 citations2006: 246 citations2007: 227 citations2008: 227 citations2009: 257 citations2010: 238 citations2011: 317 citations2012: 269 citations2013: 245 citations2014: 219 citations2015: 236 citations2016: 169 citations2017: 229 citations2018: 159 citations2019: 536 citations2020: 763 citations2021: 700 citations2022: 440 citations2023: 369 citations2024: 456 citations2025: 230 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,061 citing papers, 32% of this breakdownUnited Kingdom: 698 citing papers, 7.3% of this breakdownItaly: 629 citing papers, 6.6% of this breakdownGermany: 544 citing papers, 5.7% of this breakdownChina: 528 citing papers, 5.5% of this breakdownNetherlands: 470 citing papers, 4.9% of this breakdownCanada: 466 citing papers, 4.8% of this breakdownFrance: 313 citing papers, 3.3% of this breakdownSwitzerland: 251 citing papers, 2.6% of this breakdownJapan: 245 citing papers, 2.5% of this breakdownAustralia: 238 citing papers, 2.5% of this breakdownSpain: 237 citing papers, 2.5% of this breakdown
0%32%Other 19.8%

Fields

  • Medicine61.3%
  • Biochemistry, Genetics and Molecular Biology32.3%
  • Neuroscience2.5%
  • Engineering1.1%
  • Immunology and Microbiology0.8%
  • Computer Science0.8%
  • Other1.2%

Topics

  • Cardiac electrophysiology and arrhythmias6.8%
  • Cardiovascular Effects of Exercise6.5%
  • Cardiomyopathy and Myosin Studies4.3%
  • Adipose Tissue and Metabolism4.3%
  • Connexins and lens biology3.2%
  • Mitochondrial Function and Pathology3.1%
  • Other71.8%

Coauthors

All papers

Open in search
  1. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Heart Rhythm 2019 cited by 806

  2. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2010 cited by 2,657

  3. Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis

    Authors: , , , , , - Journal of Clinical Investigation 2000 cited by 1,270

  4. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2010 cited by 1,599

  5. PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis

    Authors: , , , , , , , , , , , , , , , , , - PLoS Biology 2005 cited by 942

  6. Molecular mechanisms of arrhythmogenic cardiomyopathy

    Authors: , , , , , , - Nature Reviews Cardiology 2019 cited by 257

  7. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy

    Authors: , , , , , , , , , , - Circulation 2019 cited by 190

  8. Phospholamban R14del Mutation in Patients Diagnosed with Dilated Cardiomyopathy or Arrhythmogenic Right Ventricular Cardiomyopathy: Evidence Supporting the Concept of Arrhythmogenic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2012 cited by 458

  9. 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Pathology 2011 cited by 528

  10. Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 91

  11. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JACC. Clinical electrophysiology 2018 cited by 184

  12. Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy

    Authors: , , , , , , , , , , , - JCI Insight 2016 cited by 179

  13. A novel mouse model of lipotoxic cardiomyopathy

    Authors: , , , , , , , - Journal of Clinical Investigation 2001 cited by 756

  14. Cardiac-Specific Induction of the Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Promotes Mitochondrial Biogenesis and Reversible Cardiomyopathy in a Developmental Stage-Dependent Manner

    Authors: , , , , , , , , , - Circulation Research 2004 cited by 392

  15. Histopathological Characterization of Radiofrequency Ablation in Ventricular Scar Tissue

    Authors: , , , , , , - JACC. Clinical electrophysiology 2019 cited by 99

  16. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Heart Rhythm 2019 cited by 185

  17. NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2024 cited by 28

  18. Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2014 cited by 274

  19. Desmosomal Dysfunction due to Mutations in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , - Circulation Research 2006 cited by 318

  20. Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene

    Authors: , , , , , , , , , , , , , , , - Heart Rhythm 2009 cited by 166

  21. A New Diagnostic Test for Arrhythmogenic Right Ventricular Cardiomyopathy

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 460

  22. Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life‐Threatening Arrhythmias

    Authors: , , , , , , , , , , , , , , , - Journal of the American Heart Association 2015 cited by 133

  23. CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation Research 2020 cited by 59

  24. Altered Electrical, Biomolecular, and Immunologic Phenotypes in a Novel Patient-Derived Stem Cell Model of Desmoglein-2 Mutant ARVC

    Authors: , , , , , , , , , , , , - Journal of Clinical Medicine 2021 cited by 41